Paige Mahaney

Insider Reports History

Location
Watertown, MA
Signature
/s/ Shagha Russell, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paige Mahaney:

Company Role Class Num Shares Value Price $ Report Date Ownership
C4 Therapeutics, Inc. Chief Scientific Officer Common Stock 336,910 $636,759 $1.89 14 Feb 2026 Direct
C4 Therapeutics, Inc. Chief Scientific Officer Stock Option (Right to Buy) 42,400 14 Feb 2025 Direct

Insider Reports Filed by Paige Mahaney

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CCCC C4 Therapeutics, Inc. 13 Feb 2026 3 -$4,623 4 Chief Scientific Officer 18 Feb 2026, 17:05
CCCC C4 Therapeutics, Inc. 28 Oct 2025 2 -$14,562 4 Chief Scientific Officer 30 Oct 2025, 16:30
CCCC C4 Therapeutics, Inc. 14 Feb 2025 2 $0 4 Chief Scientific Officer 18 Feb 2025, 16:54
CCCC C4 Therapeutics, Inc. 28 Oct 2024 2 $0 4 Chief Scientific Officer 29 Oct 2024, 16:31
CCCC C4 Therapeutics, Inc. 28 Oct 2024 0 $0 3 Chief Scientific Officer 29 Oct 2024, 16:30